Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2011-A01659-32 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre Régional de Référence en Cancérologie | OTHER |
| National Cancer Institute, France | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is an multicenter study for preventive and therapeutic strategies for patients with head and neck cancer
Continuing the chronic intoxication by either tobacco or alcohol after the initial diagnosis of a first lung or head and neck cancer significantly improves the risk of experiencing a second cancer, and largely affects the long term survival. Addiction intervention programs should be personalized according to the patient's profile, with the aim to develop more sustained intervention and monitoring in patients identified at higher risk of not spontaneously stopping harmful substance use. As of today, the trajectories of smoking and drinking habits and the risk factors for persisting smoking or drinking habits have been insufficiently explored among patients with a first lung or head and neck cancer.
The ALTAK study aims to depict the rate of tobacco smokers 12 months after the initial diagnosis of a first lung or head and neck cancer. The secondary objectives of the study are:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| head and neck or lung cancer | patient with a first head and neck cancer or first lung cancer |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| physician assessment | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| tobacco consumption | reported tobacco smoking | at 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| tobacco smoking | frequency tobacco consumption | at baseline, 3 and 6 months |
| alcohol drinking | frequency of alcohol consumption | at baseline, 3, 6 and 12 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
patient with a first head and neck cancer or first lung cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Corinne VANNIMENUS, MD | Centre Hospitalier Régional et Universitaire LILLE | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier Régional et Universitaire - Hopital CALMETTE | Lille | 59 037 | France | |||
| Centre Hospitalier Régional et Universitaire - Hopital HURIEZ |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29614983 | Derived | Vannimenus C, Bricout H, Le Rouzic O, Mouawad F, Chevalier D, Dansin E, Rotsaert L, Lefebvre G, Cottencin O, Porte H, Scherpereel A, El Fahsi A, Richard F, Rolland B; ALTAK Study Group. Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study. BMC Cancer. 2018 Apr 3;18(1):372. doi: 10.1186/s12885-018-4253-5. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006258 | Head and Neck Neoplasms |
| D008175 | Lung Neoplasms |
| D014029 | Tobacco Use Disorder |
| D000437 | Alcoholism |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| progression free survival | median time between date of inclusion and date of first progression | at 12 months |
| overall survival | median time between date of inclusion and date of death | at 12 months |
| sociodemographic, cancer-related, tobacco-related, alcohol-related, and psychiatric characteristics | at baseline |
| Lille |
| 59 037 |
| France |
| Oscar Lambret Center | Lille | 59020 | France |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
| D019973 | Alcohol-Related Disorders |